RNASeq of AB5075 _gigB strain: Following Kanamycin Exposure

SRX2568047 gigB kan 3 RNASeq of AB5075 _gigB strain: Following Kanamycin Exposure SRP100071 PRJNA375077 SRS1984420 SAMN06342413 gigB kan 3 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568048 gigB kan 2 RNASeq of AB5075 _gigB strain: Following Kanamycin Exposure SRP100071 PRJNA375077 SRS1984422 SAMN06342412 gigB kan 2 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568049 gigB kan 1 RNASeq of AB5075 _gigB strain: Following Kanamycin Exposure SRP100071 PRJNA375077 SRS1984423 SAMN06342411 gigB kan 1 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568050 gigB exp phase 3 RNASeq of AB5075 _gigB strain: Exponential Phase SRP100071 PRJNA375077 SRS1984421 SAMN06342410 gigB exp phase 3 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568051 gigB exp phase 2 RNASeq of AB5075 _gigB strain: Exponential Phase SRP100071 PRJNA375077 SRS1984424 SAMN06342409 gigB exp phase 2 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568052 gigB exp phase 1 RNASeq of AB5075 _gigB strain: Exponential Phase SRP100071 PRJNA375077 SRS1984426 SAMN06342408 gigB exp phase 1 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568053 gigA kan 3 RNASeq of AB5075 _gigA strain: Following Kanamycin Exposure SRP100071 PRJNA375077 SRS1984425 SAMN06342407 gigA kan 3 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568054 gigA kan 2 RNASeq of AB5075 _gigA strain: Following Kanamycin Exposure SRP100071 PRJNA375077 SRS1984427 SAMN06342406 gigA kan 2 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568055 gigA kan 1 RNASeq of AB5075 _gigA strain: Following Kanamycin Exposure SRP100071 PRJNA375077 SRS1984428 SAMN06342405 gigA kan 1 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568056 gigA exp phase 3 RNASeq of AB5075 _gigA strain: Exponential Phase SRP100071 PRJNA375077 SRS1984429 SAMN06342404 gigA exp phase 3 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568057 gigA exp phase 2 RNASeq of AB5075 _gigA strain: Exponential Phase SRP100071 PRJNA375077 SRS1984430 SAMN06342403 gigA exp phase 2 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568058 gigA exp phase 1 RNASeq of AB5075 _gigA strain: Exponential Phase SRP100071 PRJNA375077 SRS1984431 SAMN06342402 gigA exp phase 1 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568059 AB5075 kan 3 RNASeq of AB5075: Following Kanamycin Exposure SRP100071 PRJNA375077 SRS1984432 SAMN06342401 AB5075 kan 3 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568060 AB5075 kan 2 RNASeq of AB5075: Following Kanamycin Exposure SRP100071 PRJNA375077 SRS1984433 SAMN06342400 AB5075 kan 2 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568061 AB5075 kan 1 RNASeq of AB5075: Following Kanamycin Exposure SRP100071 PRJNA375077 SRS1984434 SAMN06342399 AB5075 kan 1 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568062 AB5075 exp phase 3 RNASeq of AB5075: Exponential Phase SRP100071 PRJNA375077 SRS1984435 SAMN06342398 AB5075 exp phase 3 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568063 AB5075 exp phase 2 RNASeq of AB5075: Exponential Phase SRP100071 PRJNA375077 SRS1984436 SAMN06342397 AB5075 exp phase 2 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500 SRX2568064 AB5075 exp phase 1 RNASeq of AB5075: Exponential Phase SRP100071 PRJNA375077 SRS1984437 SAMN06342396 AB5075 exp phase 1 RNA-Seq TRANSCRIPTOMIC cDNA Illumina HiSeq 2500